{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:46:56Z","timestamp":1792482416851,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007834","name":"National Nature Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81172861, No. 81172352, and No. 81472269"],"award-info":[{"award-number":["No. 81172861, No. 81172352, and No. 81472269"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002894","name":"Foundation of Scientific and Technological Project of Shandong Province","doi-asserted-by":"publisher","award":["No. 2011GG21829 and No. 2015GSF118047"],"award-info":[{"award-number":["No. 2011GG21829 and No. 2015GSF118047"]}],"id":[{"id":"10.13039\/100002894","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jbspin.2015.07.006","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T09:29:07Z","timestamp":1451986147000},"page":"282-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner"],"prefix":"10.1016","volume":"83","author":[{"given":"Zhaowen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.07.006_bib0155","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2012.01.013","article-title":"The role of neutrophils in autoimmune diseases","volume":"143","author":"Nemeth","year":"2012","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar4325","article-title":"Role of neutrophils in systemic autoimmune diseases","volume":"15","author":"Kaplan","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.autrev.2009.12.013","article-title":"Neutrophils in rheumatoid arthritis: more than simple final effectors","volume":"9","author":"Cascao","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0175","series-title":"Rheumatoid Arthritis - Etiology, Consequences and Co-Morbidities","first-page":"59","article-title":"The Role of Neutrophils in Rheumatoid Arthritis\u2013Experiments In Vitro: A Change of Conception?","author":"Michal","year":"2012"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0180","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil function in inflammation and inflammatory diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/ar3308","article-title":"Soluble IL-18 receptor complex: a new star in the firmament of rheumatoid arthritis diagnosis?","volume":"13","author":"van de Loo","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0190","first-page":"144","article-title":"Caspase-1 is active since the early phase of rheumatoid arthritis","volume":"30","author":"Cascao","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0195","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3899\/jrheum.120594","article-title":"Agreement between the DAS28-CRP assessed with 3 and 4 variables in patients with rheumatoid arthritis treated with biological agents in the daily clinic","volume":"40","author":"Madsen","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0205","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1681\/ASN.2004070609","article-title":"Membrane proteinase 3 expression in patients with Wegener's granulomatosis and in human hematopoietic stem cell-derived neutrophils","volume":"16","author":"Schreiber","year":"2005","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0210","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chom.2010.11.007","article-title":"Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing","volume":"8","author":"Broz","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0215","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1038\/cddis.2012.86","article-title":"Caspase-1: is IL-1 just the tip of the ICEberg?","volume":"3","author":"Denes","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0220","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2006.09.006","article-title":"Caspase-1 builds a new barrier to infection","volume":"126","author":"Saleh","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0225","first-page":"a008680","article-title":"Caspase substrates and inhibitors","volume":"5","author":"Poreba","year":"2013","journal-title":"Perspect Biol"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/art.10814","article-title":"Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis","volume":"48","author":"Joosten","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0235","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/ard.2003.016428","article-title":"Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis","volume":"63","author":"Rooney","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0240","first-page":"1","article-title":"Interleukin-18 expression in rheumatoid artheritis synovial tissue and its relation to disease activity","volume":"14","author":"Gouda","year":"2007","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0245","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1503\/cmaj.091391","article-title":"A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview","volume":"181","author":"Singh","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0250","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1345\/aph.1R203","article-title":"Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis","volume":"46","author":"Desai","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0255","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1477-7525-12-102","article-title":"Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis","volume":"12","author":"Jansen","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3899\/jrheum.130310","article-title":"Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus","volume":"41","author":"Yang","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0265","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrrheum.2009.278","article-title":"Sensors of the innate immune system: their link to rheumatic diseases","volume":"6","author":"Theofilopoulos","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.2008.00730.x","article-title":"Inflammasomes: guardians of cytosolic sanctity","volume":"227","author":"Lamkanfi","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0275","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0285","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0290","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1084\/jem.20100050","article-title":"The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer","volume":"207","author":"Allen","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0295","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ibd.21478","article-title":"NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis","volume":"17","author":"Hirota","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jbspin.2015.07.006_bib0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.it.2011.02.002","article-title":"The Nlrp3 inflammasome: contributions to intestinal homeostasis","volume":"32","author":"Zaki","year":"2011","journal-title":"Trends Immunol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15002705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15002705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T06:52:58Z","timestamp":1537080778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15002705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1297319X15002705"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.07.006","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caspase-1 mediated interleukin-18 activation in neutrophils promotes the activity of rheumatoid arthritis in a NLRP3 inflammasome independent manner","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}